IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Association of Ghrelin Levels with Insulin Resistance in Iraqi Patients with Myocardial Infarction

Author: HAMSAGHWAMER GHAZI, NAWALM.J.AL-SHAMMAA
Abstract: Ghrelin, a peptide hormone is accountable for alteration in energy balance pretentious by nutrition and growth hormone secretion. Furthermore, it too controls glucose metabolism. Revisions have proposed that ghrelinlevels change in diverse functional disorders such as heart diseases and diabetes mellitus. The aspire of the study was to equate the ghrelin concentrations in myocardial infarction patients with and without diabetes and to examine if there is any relationship between ghrelin and insulin resistance. A entire number of 150individuals were conducted in the study, among them 50 myocardial infarction patients were suffering from type 2 diabetes mellitus, 50 myocardial infarction patients were not suffering from diabetes, and 50 were healthy as control group. Fasting serum glucose, lipid profile, urea, creatinine, serum insulin, and ghrelin levels were measured. There was a significant rise(p< 0.05) in fasting serum glucose, all lipids except high density lipoprotein cholesterol, urea, and creatinine in myocardial infarction patients with type 2 diabetes as paralleled to the control. Moreover, there was a substantial reduction (p< 0.05) in serum ghrelin inmyocardial infarction patients with and without diabetes as compared to the controls [19.15±4.77 (diabetic), 21.19±4.09 (non-diabetic), 30.46±7.54 (control)]. Insulin resistance was detected in myocardial infarction patients and was connected with a cardiovascular risk features, an adverse disease progression and impaired lipid metabolism. This revision illustrated that hyperglycemia might result in defeat of ghrelin levels in type 2 diabetic patients.
Keyword: Myocardial infarction, Insulin resistance, lipid profile, Ghrelin.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.018
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free